Related references
Note: Only part of the references are listed.Elevated phosphodiester and T2 levels can be measured in the absence of fat infiltration in Duchenne muscular dystrophy patients
M. T. Hooijmans et al.
NMR IN BIOMEDICINE (2017)
Quantitative Dixon MRI sequences to relate muscle atrophy and fatty degeneration with range of motion and muscle force in brachial plexus injury
Bouke J. Duijnisveld et al.
MAGNETIC RESONANCE IMAGING (2017)
Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up
M. T. Hooijmans et al.
PLOS ONE (2017)
Leptin and metabolic syndrome in patients with Duchenne/Becker muscular dystrophy
M. Rodriguez-Cruz et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Multi-omics enrichment analysis using the GeneTrail2 web service
Daniel Stoeckel et al.
BIOINFORMATICS (2016)
Biomarkers in sarcopenia: A multifactorial approach
Francesco Curcio et al.
EXPERIMENTAL GERONTOLOGY (2016)
Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients
Barbara Janssen et al.
NEUROLOGY (2016)
Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients
Stijn Oonk et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children
Yetrib Hathout et al.
SCIENTIFIC REPORTS (2016)
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies
Jeremy Rouillon et al.
HUMAN MOLECULAR GENETICS (2015)
204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands
Alessandra Ferlini et al.
NEUROMUSCULAR DISORDERS (2015)
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Yetrib Hathout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
Anna M. L. Coenen-Stass et al.
SCIENTIFIC REPORTS (2015)
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
Nathan A. Stephens et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients
Laurence Jeanson-Leh et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
Burcu Ayoglu et al.
EMBO MOLECULAR MEDICINE (2014)
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients
Yetrib Hathout et al.
HUMAN MOLECULAR GENETICS (2014)
Dystrophin levels and clinical severity in Becker muscular dystrophy patients
J. C. van den Bergen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Fibronectin is a serum biomarker for Duchenne muscular dystrophy
F. Cynthia Martin et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
DMD transcript imbalance determines dystrophin levels
Pietro Spitali et al.
FASEB JOURNAL (2013)
195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands
Juliet A. Ellis et al.
NEUROMUSCULAR DISORDERS (2013)
Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models
Stephanie M. Gritz et al.
HUMAN GENOMICS (2013)
Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains
Maaike van Putten et al.
NEUROMUSCULAR DISORDERS (2012)
Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa-guanidine Morpholino Oligomer Treatment
Jagjeet K. Kang et al.
MOLECULAR THERAPY (2011)
Muscle histology vs MRI in Duchenne muscular dystrophy
M. Kinali et al.
NEUROLOGY (2011)
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)
V. D. Nadarajah et al.
NEUROMUSCULAR DISORDERS (2011)
Aberrant repair and fibrosis development in skeletal muscle
Christopher J. Mann et al.
SKELETAL MUSCLE (2011)
Elevated transforming growth factor beta and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts
Carola Krause et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
Dystrophin is a microtubule-associated protein
Kurt W. Prins et al.
JOURNAL OF CELL BIOLOGY (2009)
Diagnosis and new treatments in muscular dystrophies
A. Y. Manzur et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
J. M. Ruijter et al.
NUCLEIC ACIDS RESEARCH (2009)
The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice
James A. Ridgley et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm
Philip Doran et al.
PROTEOMICS (2009)
Diagnosis and new treatments in muscular dystrophies
A. Y. Manzur et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy
Ann-Charlott Soderpalm et al.
NEUROMUSCULAR DISORDERS (2007)
Development of a french isometric strength normative database for adults using quantitative muscle testing
Jean-Yves Hogrel et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2007)
Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4
Yin Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression
Mario Pescatori et al.
FASEB JOURNAL (2007)
Gene expression profiling of Duchenne muscular dystrophy skeletal muscle
JN Haslett et al.
NEUROGENETICS (2003)
Tissue-specific inactivation of murine M6P/IGF2R
AA Wylie et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
JN Haslett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
